SATVI researchers have published a journal article titled "HLA-DR Marks recently divided Antigen-Specific effector CD4 T Cells in active Tuberculosis patients" appearing in the EBioMedicine journal.
The South African Tuberculosis Vaccine Initiative is inviting applications for a Postdoctoral Fellowship in Single Cell Immunology. CLOSED.
The New England Journal of Medicine has just published the results of a clinical study which shows that in a randomised phase 3 clinical trial, a shortened 4-month TB treatment was equivalent to the standard 6-month TB treatment.
The Lancet Global Health journal reports the findings of a study of a host blood test that can find those at high risk of tuberculosis in people living with HIV. The blood mRNA biomarker differentiated between people living with HIV who had active tuberculosis from those without TB, and predicted which individuals would develop TB within 15 months.